A phase II study of temozolomide and radiation therapy in patients with brain metastasis from non-small cell lung cancer (NSCLC).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Temozolomide (Primary)
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Feb 2013 Biomarkers information updated
- 22 Aug 2011 Actual end date (February 2009) added as reported by ClinicalTrials.gov.
- 22 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.